Securing the Artificial Pancreas
Humanity+ - 21-May-2015Simple devices measure blood sugar and transmits that value to an insulin pump. Resilience of ar...
Yogish Kudva
Endocrinologist and Diabetes researcher at Mayo Clinic.
The research of Yogish C. Kudva, M.B.B.S., centers on improving existing treatments and developing novel therapies for patients with type 1 diabetes. In particular, Dr. Kudva is interested in developing an effective artificial pancreas system to improve outcomes for patients with type 1 diabetes. Additionally, his research contributes to the creation of new and better cell replacement therapies for patients with type 1 diabetes.
Dr. Kudva has played a key role in the development of the Diabetes Technology Clinic and program, started in 2003 at Mayo Clinic's campus in Rochester, Minnesota. The infrastructure set up by this program resulted in NIH funding for further research in the field of closed-loop (artificial pancreas) therapy for type 1 diabetes. The program is now well-positioned to test the system for weeks to months in the years to come as part of national and international consortia.
Visit website: https://www.mayoclinic.org/biographies/kudva-yogish-c-m-b-b-s/bio-20054325
See also: 
Mayo Clinic
- Non-profit American academic medical center focused on health care, education, and research
Details last updated 09-Aug-2020
Yogish Kudva News
